Boston Scientific’s $925 Million Acquisition of Preventice Solutions

Latham & Watkins LLP represented Preventice Solutions, Inc. in the transaction. Boston Scientific (NYSE: BSX) entered into a definitive agreement to acquire Preventice Solutions, Inc., a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now